Weiss Asset Management
FBIO icon

Weiss Asset Management’s Fortress Biotech FBIO Stock Holding History

Weiss Asset Management’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,027
Closed -$91K – 400
2019
Q2 		$91K Buy
+4,027
New +$104K 0.01% 300

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

Weiss Asset Management's FBIO Position: Q3 2019 in Review

Weiss Asset Management sold out of Fortress Biotech (FBIO) in Q3 2019, closing a stake of 4,027 shares — an estimated $91K sold.

Weiss Asset Management first reported a position in FBIO in Q2 2019 and held it in 1 quarter. The position peaked at $91K in Q2 2019. 49 funds tracked by Wall St. Rank hold FBIO as of Q3 2019.

  • Weiss Asset Management reported no remaining Fortress Biotech position as of Q3 2019 after selling out during the quarter.
  • Weiss Asset Management sold 4,027 Fortress Biotech shares in Q3 2019, an estimated $91K.
  • Weiss Asset Management first reported a position in Fortress Biotech in Q2 2019 and held it in 1 quarter.
  • Weiss Asset Management's Fortress Biotech position peaked at $91K in Q2 2019.
  • 49 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2019.

Based on Weiss Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.